Tianshui Zhongxing Bio-technology Co Ltd (002772) — Working Capital to Net Assets Ratio
Tianshui Zhongxing Bio-technology Co Ltd (002772) has a Working Capital to Net Assets ratio of 44.9% as of September 2025. Working capital of CN¥1.53 Billion (current assets of CN¥2.95 Billion minus current liabilities of CN¥1.43 Billion) is measured against net assets of CN¥3.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Tianshui Zhongxing Bio-technology Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tianshui Zhongxing Bio-technology Co Ltd Working Capital to Net Assets (2011–2024)
This chart shows how Tianshui Zhongxing Bio-technology Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 44.9%, reflecting working capital of CN¥1.53 Billion against net assets of CN¥3.40 Billion CNY. Check Tianshui Zhongxing Bio-technology Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Tianshui Zhongxing Bio-technology Co Ltd (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 002772 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 33.6% | CN¥1.12 Billion | CN¥3.32 Billion | CN¥2.83 Billion | CN¥1.71 Billion | ▼ -1.3 pp |
| 2023 | 34.9% | CN¥1.20 Billion | CN¥3.44 Billion | CN¥2.66 Billion | CN¥1.46 Billion | ▼ -12.2 pp |
| 2022 | 47.1% | CN¥1.59 Billion | CN¥3.38 Billion | CN¥3.04 Billion | CN¥1.44 Billion | ▼ -22.4 pp |
| 2021 | 69.5% | CN¥2.26 Billion | CN¥3.25 Billion | CN¥3.08 Billion | CN¥819.53 Million | ▲ +19.6 pp |
| 2020 | 49.8% | CN¥1.36 Billion | CN¥2.73 Billion | CN¥2.22 Billion | CN¥853.69 Million | ▼ -4.6 pp |
| 2019 | 54.4% | CN¥1.42 Billion | CN¥2.60 Billion | CN¥1.82 Billion | CN¥404.23 Million | ▲ +14.7 pp |
| 2018 | 39.7% | CN¥1.05 Billion | CN¥2.63 Billion | CN¥1.37 Billion | CN¥326.87 Million | ▼ -22.7 pp |
| 2017 | 62.4% | CN¥1.64 Billion | CN¥2.63 Billion | CN¥1.95 Billion | CN¥308.16 Million | ▲ +9.7 pp |
| 2016 | 52.7% | CN¥1.21 Billion | CN¥2.29 Billion | CN¥1.57 Billion | CN¥361.77 Million | ▲ +28.2 pp |
| 2015 | 24.5% | CN¥254.46 Million | CN¥1.04 Billion | CN¥531.36 Million | CN¥276.91 Million | ▼ -18.1 pp |
| 2014 | 42.6% | CN¥212.02 Million | CN¥498.05 Million | CN¥331.86 Million | CN¥119.84 Million | ▲ +5.5 pp |
| 2013 | 37.1% | CN¥151.14 Million | CN¥407.25 Million | CN¥209.09 Million | CN¥57.95 Million | ▲ +16.9 pp |
| 2012 | 20.2% | CN¥71.11 Million | CN¥351.30 Million | CN¥125.48 Million | CN¥54.37 Million | ▲ +5.8 pp |
| 2011 | 14.4% | CN¥26.20 Million | CN¥181.49 Million | CN¥77.59 Million | CN¥51.39 Million | — |